Harvard Bioscience PE Ratio 2012-2026 | HBIO
Current and historical p/e ratio for Harvard Bioscience (HBIO) from 2012 to 2026. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. Harvard Bioscience PE ratio as of June 05, 2026 is 0.00.
| Harvard Bioscience PE Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | TTM Net EPS | PE Ratio |
| 2026-06-08 | 6.01 | 0.00 | |
| 2026-03-31 | 4.87 | $-0.91 | 0.00 |
| 2025-12-31 | 6.69 | $-1.28 | 0.00 |
| 2025-09-30 | 4.39 | $-1.21 | 0.00 |
| 2025-06-30 | 4.44 | $-1.29 | 0.00 |
| 2025-03-31 | 5.66 | $-1.31 | 0.00 |
| 2024-12-31 | 21.10 | $-0.28 | 0.00 |
| 2024-09-30 | 26.90 | $-0.33 | 0.00 |
| 2024-06-30 | 28.50 | $-0.25 | 0.00 |
| 2024-03-31 | 42.40 | $-0.20 | 0.00 |
| 2023-12-31 | 53.50 | $-0.08 | 0.00 |
| 2023-09-30 | 43.00 | $-0.08 | 0.00 |
| 2023-06-30 | 54.90 | $-0.13 | 0.00 |
| 2023-03-31 | 42.00 | $-0.05 | 0.00 |
| 2022-12-31 | 27.70 | $-0.23 | 0.00 |
| 2022-09-30 | 25.60 | $-0.17 | 0.00 |
| 2022-06-30 | 36.00 | $-0.09 | 0.00 |
| 2022-03-31 | 62.10 | $-0.16 | 0.00 |
| 2021-12-31 | 70.50 | $-0.01 | 0.00 |
| 2021-09-30 | 69.80 | $-0.04 | 0.00 |
| 2021-06-30 | 83.30 | $-0.07 | 0.00 |
| 2021-03-31 | 54.60 | $-0.10 | 0.00 |
| 2020-12-31 | 42.90 | $-0.20 | 0.00 |
| 2020-09-30 | 30.10 | $-0.17 | 0.00 |
| 2020-06-30 | 31.00 | $-0.21 | 0.00 |
| 2020-03-31 | 22.10 | $-0.18 | 0.00 |
| 2019-12-31 | 30.50 | $-0.12 | 0.00 |
| 2019-09-30 | 30.75 | $-0.06 | 0.00 |
| 2019-06-30 | 20.00 | $0.00 | 0.00 |
| 2019-03-31 | 43.10 | $-0.03 | 0.00 |
| 2018-12-31 | 31.80 | $-0.08 | 0.00 |
| 2018-09-30 | 52.50 | $-0.13 | 0.00 |
| 2018-06-30 | 53.50 | $-0.13 | 0.00 |
| 2018-03-31 | 50.00 | $-0.10 | 0.00 |
| 2017-12-31 | 33.00 | $-0.02 | 0.00 |
| 2017-09-30 | 37.50 | $-0.09 | 0.00 |
| 2017-06-30 | 25.50 | $-0.13 | 0.00 |
| 2017-03-31 | 26.00 | $-0.14 | 0.00 |
| 2016-12-31 | 30.50 | $-0.13 | 0.00 |
| 2016-09-30 | 27.20 | $-0.61 | 0.00 |
| 2016-06-30 | 28.60 | $-0.58 | 0.00 |
| 2016-03-31 | 30.20 | $-0.55 | 0.00 |
| 2015-12-31 | 34.70 | $-0.57 | 0.00 |
| 2015-09-30 | 37.80 | $-0.05 | 0.00 |
| 2015-06-30 | 57.00 | $-0.01 | 0.00 |
| 2015-03-31 | 58.20 | $0.01 | 5820.00 |
| 2014-12-31 | 56.70 | $0.07 | 810.00 |
| 2014-09-30 | 40.90 | $0.05 | 818.00 |
| 2014-06-30 | 45.50 | $0.00 | 0.00 |
| 2014-03-31 | 47.40 | $-0.04 | 0.00 |
| 2013-12-31 | 47.00 | $-0.06 | 0.00 |
| 2013-09-30 | 39.85 | $-0.01 | 0.00 |
| 2013-06-30 | 35.61 | $0.02 | 1780.50 |
| 2013-03-31 | 42.81 | $0.06 | 713.46 |
| 2012-12-31 | 33.19 | $0.08 | 414.82 |
| 2012-09-30 | 32.05 | $0.07 | 457.84 |
| 2012-06-30 | 28.56 | $0.07 | 408.05 |
| 2012-03-31 | 29.70 | $0.09 | 330.00 |
| 2011-12-31 | 29.32 | $0.13 | 225.55 |
| 2011-09-30 | 31.97 | $0.19 | 168.28 |
| 2011-06-30 | 40.38 | $0.63 | 64.10 |
| 2011-03-31 | 43.04 | $0.64 | 67.24 |
| 2010-12-31 | 30.91 | $0.65 | 47.56 |
| 2010-09-30 | 28.79 | $0.70 | 41.13 |
| 2010-06-30 | 26.97 | $0.30 | 89.91 |
| 2010-03-31 | 29.32 | $0.25 | 117.29 |
| 2009-12-31 | 27.05 | $0.24 | 112.70 |
| 2009-09-30 | 28.72 | $0.17 | 168.91 |
| 2009-06-30 | 29.93 | $0.17 | 176.04 |
| 2009-03-31 | 22.58 | $0.09 | 250.87 |
| 2008-12-31 | 20.08 | $0.05 | 401.56 |
| 2008-09-30 | 35.23 | $-0.05 | 0.00 |
| 2008-06-30 | 35.23 | $-0.05 | 0.00 |
| 2008-03-31 | 37.88 | $-0.04 | 0.00 |
| 2007-12-31 | 34.70 | $-0.04 | 0.00 |
| 2007-09-30 | 34.09 | $-0.08 | 0.00 |
| 2007-06-30 | 39.78 | $-0.13 | 0.00 |
| 2007-03-31 | 36.52 | $-0.08 | 0.00 |
| 2006-12-31 | 38.87 | $-0.08 | 0.00 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Computer and Technology | Scientific Instruments Manufacturing | $0.019B | $0.087B |
| HARVARD BIOSCIENCE develops, manufactures and markets tools used in drug discovery research at pharmaceutical and biotechnology companies, universities and government laboratories. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Bruker (BRKR) | United States | $5.722B | 20.54 |
| Kewaunee Scientific (KEQU) | United States | $0.100B | 8.24 |